Cyteir Therapeutics Q4 EPS $(0.34) Beats $(0.39) Estimate

Cyteir Therapeutics (NASDAQ:CYT) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.39) by 12.82 percent.

Cyteir Therapeutics (NASDAQ:CYT) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.39) by 12.82 percent.

Total
0
Shares
Related Posts